Krahé, C, Brown, C, Twiddy, H, Frank, B, Brian, E, Nurmikko, T, Stancak, A and Fallon, N (2023) Effects of Lockdown Restrictions and Impact of Anxiety and Depression Symptoms in People With Chronic Pain During the Covid-19 Pandemic: A 13-wave Longitudinal Study. The Journal of Pain. ISSN 1526-5900

Rajeev, SP, Roberts, CA, Brown, E, Sprung, VS, Harrold, JA, Halford, JCG, Stancak, A, Boyland, EJ, Kemp, GJ, Perry, J, Howarth, E, Jackson, R, Wiemken, A, Schwab, R, Cuthbertson, DJ and Wilding, JPH (2023) No evidence of compensatory changes in energy balance, despite reductions in body weight and liver fat, during dapagliflozin treatment in type 2 diabetes mellitus: A randomised, double-blind, placebo-controlled, cross-over trial (ENERGIZE). Diabetes, Obesity and Metabolism. ISSN 1462-8902

Hewitt, D, Byrne, A, Henderson, J, Wilford, K, Chawla, R, Sharma, ML, Frank, B, Fallon, N, Brown, C and Stancak, A (2022) Pulse Intensity Effects of Burst and Tonic Spinal Cord Stimulation on Neural Responses to Brushing in Patients With Neuropathic Pain. Neuromodulation: Technology at the Neural Interface, 26 (5). pp. 975-987. ISSN 1094-7159

Brown, E, Wilton, MM, Sprung, VS, Harrold, JA, Halford, JCG, Stancak, A, Burgess, M, Howarth, E, Umpleby, AM, Kemp, GJ, Wilding, JPH and Cuthbertson, DJ (2021) A randomised, controlled, double blind study to assess mechanistic effects of combination therapy of dapagliflozin with exenatide QW versus dapagliflozin alone in obese patients with type 2 diabetes mellitus (RESILIENT): study protocol. BMJ Open, 11 (7). ISSN 2044-6055

Rajeev, SP, Sprung, VS, Roberts, C, Harrold, JA, Halford, JCG, Stancak, A, Boyland, EJ, Kemp, GJ, Cuthbertson, DJ and Wilding, JPH (2017) Compensatory changes in energy balance during dapagliflozin treatment in type 2 diabetes mellitus: a randomised double-blind, placebo-controlled, cross-over trial (ENERGIZE)-study protocol. BMJ, 7 (1). ISSN 1756-1833